Approbation of the Cancer Treatment Approach Based on the Eradication of TAMRA+ Cancer Stem Cells in a Model of Murine Cyclophosphamide Resistant Lymphosarcoma.
Polina E KisaretovaSvetlana S KirikovichGenrich S RitterYaroslav R EfremovOleg S TaranovTatyana D DubatolovaAnastasia S ProskurinaEkaterina A PotterEvgenia V DolgovaSergey V SidorovAleksandr A OstaninElena R ChernykhSergey S BogachevPublished in: Anticancer research (2020)
The "3+1" approach resulted in the elimination of cancer stem cells, and, as a consequence, in the complete reduction of RLS ascites.